This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Aug 31;382(9894):748-9.

doi: 10.1016/S0140-6736(13)60739-4. Epub 2013 Jun 13.

Ustekinumab for psoriatic arthritis: close to the PSUMMIT?

Richard B Warren¹, Hector Chinoy

Affiliations

PMID: 23769295
DOI: 10.1016/S0140-6736(13)60739-4

Comment

Ustekinumab for psoriatic arthritis: close to the PSUMMIT?

Richard B Warren et al. Lancet. 2013.

. 2013 Aug 31;382(9894):748-9.

doi: 10.1016/S0140-6736(13)60739-4. Epub 2013 Jun 13.

Authors

Richard B Warren¹, Hector Chinoy

Affiliation

¹ Dermatology Centre, Salford Royal National Health Service Foundation Trust, University of Manchester, Manchester M6 8HD, UK. richard.warren@manchester.ac.uk

PMID: 23769295
DOI: 10.1016/S0140-6736(13)60739-4

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
McInnes IB, Kavanaugh A, Gottlieb AB, Puig L, Rahman P, Ritchlin C, Brodmerkel C, Li S, Wang Y, Mendelsohn AM, Doyle MK; PSUMMIT 1 Study Group. McInnes IB, et al. Lancet. 2013 Aug 31;382(9894):780-9. doi: 10.1016/S0140-6736(13)60594-2. Epub 2013 Jun 13. Lancet. 2013. PMID: 23769296 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information